Patch test results with the European baseline series, 2019/20-Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC
DC Element | Wert | Sprache |
---|---|---|
dc.contributor.author | Uter, Wolfgang | |
dc.contributor.author | Wilkinson, S. Mark | |
dc.contributor.author | Aerts, Olivier | |
dc.contributor.author | Bauer, Andrea | |
dc.contributor.author | Borrego, Leopoldo | |
dc.contributor.author | Brans, Richard | |
dc.contributor.author | Buhl, Timo | |
dc.contributor.author | Dickel, Heinrich | |
dc.contributor.author | Dugonik, Aleksandra | |
dc.contributor.author | Filon, Francesca Larese | |
dc.contributor.author | Garcia, Pedro Mercader | |
dc.contributor.author | Gimenez-Arnau, Ana | |
dc.contributor.author | Patruno, Cataldo | |
dc.contributor.author | Pesonen, Maria | |
dc.contributor.author | Ponyai, Gyorgyi | |
dc.contributor.author | Rustemeyer, Thomas | |
dc.contributor.author | Schubert, Steffen | |
dc.contributor.author | Schuttelaar, Marie-L A. | |
dc.contributor.author | Simon, Dagmar | |
dc.contributor.author | Stingeni, Luca | |
dc.contributor.author | Valiukeviciene, Skaidra | |
dc.contributor.author | Weisshaar, Elke | |
dc.contributor.author | Werfel, Thomas | |
dc.contributor.author | Goncalo, Margarida | |
dc.contributor.author | ESSCA Working Grp | |
dc.contributor.author | EBS ESCD Working Grp | |
dc.contributor.author | Geidac | |
dc.date.accessioned | 2023-02-17T11:36:57Z | - |
dc.date.available | 2023-02-17T11:36:57Z | - |
dc.date.issued | 2022 | |
dc.identifier.issn | 0105-1873 | |
dc.identifier.uri | http://osnascholar.ub.uni-osnabrueck.de/handle/unios/65649 | - |
dc.description.abstract | Background Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens. Objectives To present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020. Methods Anonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed. Results In 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2-20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43-7.19)% and 6.62 (6.25-7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16-2.85]% vs. 1.59 [1.33-1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16-3.82]%), followed by 2-hydroxyethyl methacrylate (2.32 [2.0-2.68]%). Conclusion Ongoing surveillance on the prevalence of contact sensitization contributes to an up-to-date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe. | |
dc.description.sponsorship | EADV [PPRC-2018-8]; Spanish Medicines and Health Products Agency (Agencia Espanola de Medicamentos y Productos Sanitarios); Sanofi; GSK; Novartis; Projekt DEAL; Partial funding by the EADV Grant PPRC-2018-8 is thankfully acknowledged. Since spring 2020, data for this study were collected during the pre-vaccine COVID-19 pandemic. We are indebted to all the doctors who were on the front lines of this war and especially to the dermatologists who supported other departments. Our deep appreciation goes to the colleagues infected during this period, our mourning to those who died. The REIDAC project is promoted by the Fundacion Piel Sana Academia Espanola de Dermatologia y Venereologia, which has received financial support from the Spanish Medicines and Health Products Agency (Agencia Espanola de Medicamentos y Productos Sanitarios; available at ), and from pharmaceutical companies (Sanofi, GSK and Novartis). Open Access funding enabled and organized by Projekt DEAL. | |
dc.language.iso | en | |
dc.publisher | WILEY | |
dc.relation.ispartof | CONTACT DERMATITIS | |
dc.subject | ALLERGIC CONTACT-DERMATITIS | |
dc.subject | Allergy | |
dc.subject | baseline series | |
dc.subject | clinical epidemiology | |
dc.subject | contact allergy | |
dc.subject | Dermatology | |
dc.subject | METHYLCHLOROISOTHIAZOLINONE/METHYLISOTHIAZOLINONE | |
dc.subject | NICKEL | |
dc.subject | patch testing | |
dc.subject | RECOMMENDATIONS | |
dc.subject | RRID | |
dc.subject | SCR_001905 | |
dc.subject | SENSITIZATION | |
dc.subject | SOCIETY | |
dc.subject | SPAIN | |
dc.subject | surveillance | |
dc.title | Patch test results with the European baseline series, 2019/20-Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC | |
dc.type | journal article | |
dc.identifier.doi | 10.1111/cod.14170 | |
dc.identifier.isi | ISI:000815350500001 | |
dc.description.volume | 87 | |
dc.description.issue | 4 | |
dc.description.startpage | 343 | |
dc.description.endpage | 355 | |
dc.contributor.orcid | 0000-0002-4498-3710 | |
dc.contributor.orcid | 0000-0001-8433-7716 | |
dc.contributor.orcid | 0000-0001-7253-3461 | |
dc.contributor.orcid | 0000-0002-0076-2887 | |
dc.contributor.orcid | 0000-0002-1245-024X | |
dc.contributor.orcid | 0000-0002-0199-2756 | |
dc.contributor.orcid | 0000-0002-7717-0417 | |
dc.contributor.researcherid | AFP-7298-2022 | |
dc.identifier.eissn | 1600-0536 | |
dc.publisher.place | 111 RIVER ST, HOBOKEN 07030-5774, NJ USA | |
dcterms.isPartOf.abbreviation | Contact Dermatitis | |
dcterms.oaStatus | Green Published, Green Accepted | |
local.import.remains | affiliations : University of Erlangen Nuremberg; University of Leeds; University of Antwerp; University of Antwerp; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Universidad de Las Palmas de Gran Canaria; University Osnabruck; University of Gottingen; Ruhr University Bochum; University of Maribor; University of Trieste; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Magna Graecia University of Catanzaro; Finnish Institute of Occupational Health; Semmelweis University; University of Groningen; University of Bern; University Hospital of Bern; University of Perugia; Lithuanian University of Health Sciences; Ruprecht Karls University Heidelberg; Hannover Medical School; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra | |
local.import.remains | earlyaccessdate : JUN 2022 | |
local.import.remains | web-of-science-index : Science Citation Index Expanded (SCI-EXPANDED) | |
crisitem.author.dept | Universität Osnabrück | - |
crisitem.author.dept | Universität Osnabrück | - |
crisitem.author.orcid | 0000-0002-1245-024X | - |
Seitenaufrufe
2
Letzte Woche
0
0
Letzter Monat
0
0
geprüft am 21.05.2024